(Q34449517)

2 August 2017

Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry (English)

1 reference

2 August 2017

0 references

1 reference

1

Diethelm Tschöpe

0 references

author name string

Diethelm Tschöpe

1

1 reference

2 August 2017

Peter Bramlage

2

1 reference

2 August 2017

Christiane Binz

3

1 reference

2 August 2017

Michael Krekler

4

1 reference

2 August 2017

Evelin Deeg

5

1 reference

2 August 2017

Anselm K Gitt

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

17 October 2012

1 reference

2 August 2017

BMC Endocrine Disorders

1 reference

2 August 2017

12

1 reference

2 August 2017

1

0 references

page(s)

23

1 reference

Creative Commons Attribution 2.0 Generic

2 August 2017

start time

17 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1472-6823-12-23

0 references

cites work

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Death during intensive glycemic therapy of diabetes: mechanisms and implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Severe hypoglycaemia in drug-treated diabetic patients needs attention: a population-based study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Hypoglycaemia: current management and controversies.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Glucose control and vascular complications in veterans with type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Effects of intensive glucose lowering in type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Intensive glycemic control in the ACCORD and ADVANCE trials

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Defining hypoglycaemia: what level has clinical relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Hypoglycemia-associated autonomic failure in advanced type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Decreased epinephrine responses to hypoglycemia during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515411

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Gender differences in counterregulation to hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-23

Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin

21 January 2018

1 reference

12 December 2020

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey

1 reference

12 December 2020

Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes

1 reference

12 December 2020

Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes

1 reference

12 December 2020

Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes

1 reference

12 December 2020

Intensified insulin therapy and the risk of severe hypoglycaemia

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients

1 reference

12 December 2020

Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6823-12-23

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference